Suppressing YBX1 with a small molecule inhibitor sensitizes lung cancer to chemotherapy

被引：1
|
作者：
Lee, Jee Min
Malhotra, Sanjay
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
513
引用
收藏
页数：2
相关论文
共 50 条
  • [31] YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma
    Zhao, Shilei
    Wang, Yan
    Guo, Tao
    Yu, Wendan
    Li, Jinxiu
    Tang, Zhipeng
    Yu, Zhenlong
    Zhao, Lei
    Zhang, Yixiang
    Wang, Ziyi
    Wang, Peng
    Li, Yechi
    Li, Fengzhou
    Sun, Zhe
    Xuan, Yang
    Tang, Ranran
    Deng, Wu-Guo
    Guo, Wei
    Gu, Chundong
    ONCOTARGET, 2016, 7 (50) : 82139 - 82157
  • [32] YBX1 Regulates Satellite II RNA Loading into Small Extracellular Vesicles and Promotes the Senescent Phenotype
    Chiba, Masatomo
    Miyata, Kenichi
    Okawa, Hikaru
    Tanaka, Yoko
    Ueda, Koji
    Seimiya, Hiroyuki
    Takahashi, Akiko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [33] Novel Serine 176 Phosphorylation of YBX1 Activates NF-B in Colon Cancer
    Martin, Matthew
    Hua, Laiqing
    Wang, Benlian
    Wei, Han
    Prabhu, Lakshmi
    Hartley, Antja-Voy
    Jiang, Guanglong
    Liu, Yunlong
    Lu, Tao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (08) : 3433 - 3444
  • [34] Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy
    Quintanal-Villalonga, Alvaro
    Taniguchi, Hirokazu
    Hao, Yuan
    Chow, Andrew
    Zhan, Yingqian A.
    Chavan, Shweta S.
    Uddin, Fathema
    Allaj, Viola
    Manoj, Parvathy
    Shah, Nisargbhai S.
    Chan, Joseph M.
    Offin, Michael
    Ciampricotti, Metamia
    Ray-Kirton, Jordana
    Egger, Jacklynn
    Bhanot, Umesh
    Linkov, Irina
    Asher, Marina
    Roehrl, Michael H.
    Qiu, Juan
    de Stanchina, Elisa
    Hollmann, Travis J.
    Koche, Richard P.
    Sen, Triparna
    Poirier, John T.
    Rudin, Charles M.
    CANCER RESEARCH, 2022, 82 (03) : 472 - 483
  • [35] Overcoming endocrine therapy resistance by drugs targeting YBX1 activation pathway in breast cancer
    Shibata, Tomohiro
    Watari, Kosuke
    Kawahara, Akihiko
    Sudo, Tomoya
    Murakami, Yuichi
    Tokunaga, Eriko
    Yamashita, Nami
    Oki, Eiji
    Maehara, Yoshihiko
    Akiba, Jun
    Akagi, Yoshito
    Tanaka, Maki
    Kuwano, Michihiko
    Ono, Mayumi
    CANCER RESEARCH, 2019, 79 (13)
  • [36] A broad role for YBX1 in defining the small non- coding RNA composition of extracellular vesicles
    Shurtleff, M. J.
    Qin, Y.
    Yao, J.
    Temoche-Diaz, M. M.
    Lambowitz, A.
    Schekman, R. W.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [37] A novel BCAT1 inhibitor bufalin sensitizes pancreatic cancer cells to chemotherapy
    Zhang, Wei
    Fan, Yibao
    Ashrafizadeh, Milad
    Shi, Dan
    Sethi, Gautam
    Ertas, Yavuz Nuri
    Abd El-Aty, A. M.
    Zhang, Xianbin
    Chen, Si
    Gong, Peng
    GENES & DISEASES, 2025, 12 (03)
  • [38] CDKL1 potentiates the antitumor efficacy of radioimmunotherapy by binding to transcription factor YBX1 and blocking PD-L1 expression in lung cancer
    Zixuan Li
    Huichan Xue
    Jinsong Li
    Zhikun Zheng
    Zhiwei Liu
    Xiaorong Dong
    Hongbo Wang
    Jing Chen
    Shuangbing Xu
    Journal of Experimental & Clinical Cancer Research, 43
  • [39] Inflammation Induced Expression of Ybx1 Mediates Resistance to JAK-Kinase Inhibitor Therapy in Myeloproliferative Neoplasia
    Herzog, Carolin
    Polanetzki, Anja
    Frey, Stephanie
    Schnoeder, Tina M.
    Wolleschak, Denise
    Mashamba, Nomusa
    Thangapandi, Veera Raghavan
    Jentsch-Ullrich, Kathleen
    Kahl, Christoph
    Schroeder, Nicolas
    Mertens, Peter R.
    Fischer, Thomas
    Heidel, Florian H.
    BLOOD, 2014, 124 (21)
  • [40] Long non-coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway
    Sun, Xianchao
    Xin, Shiyong
    Zhang, Ying
    Jin, Liang
    Liu, Xiang
    Zhang, Jiaxin
    Mei, Wangli
    Zhang, Bihui
    Ma, Weiguo
    Ye, Lin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 61 (03)
12345